In this regard, we have previously described one patient with NPM1-mutated AML unfit for intensive chemotherapy because of concomitant heart failure and refractory to 5-azacytidine, successfully treated with single-agent dactinomycin [24]. Here, NPM1 is linked to acute myeloid leukemia.